Welcome

Glioma is the most common form of primary, malignant brain tumour in adults. It is relatively rare, but has high mortality and poor prognosis, thus carrying a high burden for the cancer patient, carer and health system.

Very little is known about what causes glioma, and how best to treat it.

This project aims to bring together Australian doctors and scientists involved in treating and researching glioma. By sharing resources and ideas, AGOG is building a strong platform for clinical and translational research into glioma.

The ultimate aims of AGOG are to identify people at risk of glioma, to provide them with optimum treatment options, and to lobby for further funding and resources.

In the shorter term, AGOG aims to help with the development of new therapies and procedures that will extend survival for the brain tumour patient, while maintaining good quality of life.

The Australian Genomics and Clinical Outcomes of High Grade Glioma (AGOG) project is funded by the Cancer Council NSW via a Strategic Research Partnership Grant.